Today’s guest post comes from Stephen Hom, EVP, Chief Commercial Officer, and Co-Founder of RIS Rx.
Stephen argues that patient affordability remains one of the most critical—and often overlooked—barriers to treatment adherence. Drawing on his experience as a community pharmacist, he suggests that cost isn’t just a financial issue—it’s a clinical one.
To learn about RIS Rx’s Benefit Patient Solution (BPS) and other tools, request your savings snapshot.
Read on for Stephen’s insights.
Read more »
Source: Post feed
